Miller Mary bought ACRV
May 18, 2026 · Form 4 insider transaction
Miller Mary bought 49,830 shares of Acrivon Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
49,830
Price
$0.00
Total value
N/A
InsiderMiller Mary
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 18, 2026
Filing dateMay 20, 2026
Shares owned after82,767
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Of these RSUs, 16.67% of the RSUs shall vest on November 18, 2026, and the remaining RSUs shall vest in 10 substantially equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.